Related Experiment Video
Updated: Mar 31, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Increased arterial inflammation in individuals with stage 3 chronic kidney disease
Richard A P Takx1,2, Megan H MacNabb1, Hamed Emami1
1Cardiac MR PET CT Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Insights
Patients with chronic kidney disease (CKD) exhibit increased arterial inflammation, even in mild stages. This inflammation is linked to reduced kidney function and occurs independently of atherosclerosis, suggesting current risk assessments may be insufficient.
Area of Science:
- Cardiovascular Imaging
- Nephrology
- Radiology
Background:
- Chronic kidney disease (CKD) is a known risk factor for atherosclerosis.
- The relationship between mild CKD and arterial inflammation remains unclear.
- 18F-FDG PET/CT is a valuable tool for assessing arterial inflammation.
Purpose of the Study:
- To compare arterial inflammation in patients with mild CKD versus matched controls.
- To investigate the association between arterial inflammation and estimated glomerular filtration rate (eGFR).
- To determine if arterial inflammation in CKD is independent of coronary artery calcification (CAC).
Main Methods:
- A retrospective study of 128 patients (64 with stage 3 CKD, 64 controls) undergoing 18F-FDG PET/CT.
- Arterial inflammation measured by 18F-FDG uptake in the ascending aorta.
- Coronary artery calcification (CAC) assessed via CT imaging.
- Analysis adjusted for background uptake and clinical risk factors.
Main Results:
- Arterial inflammation was significantly higher in CKD patients compared to controls (SUV: 2.41 ± 0.49 vs. 2.16 ± 0.43, p=0.002).
- Arterial inflammation correlated inversely with eGFR (r=-0.299, p=0.001).
- Increased arterial inflammation in CKD was independent of CAC and clinical risk factors.
Conclusions:
- Moderate CKD is associated with elevated arterial inflammation.
- This inflammation is independent of subclinical atherosclerosis (CAC).
- Current cardiovascular risk stratification may underestimate atherosclerosis risk in CKD patients.
Purpose:
While it is well known that patients with chronic kidney disease (CKD) are at increased risk for the development and progression of atherosclerosis, it is not known whether arterial inflammation is increased in mild CKD. The aim of this study was to compare arterial inflammation using 18F-FDG PET/CT in patients with CKD and in matched controls.
Methods:
This restrospective study included 128 patients undergoing FDG PET/CT imaging for clinical indications, comprising 64 patients with stage 3 CKD and 64 control patients matched by age, gender, and cancer history. CKD was defined according to guidelines using a calculated glomerular filtration rate (eGFR). Arterial inflammation was measured in the ascending aorta as FDG uptake on PET. Background FDG uptake (venous, subcutaneous fat and muscle) were recorded. Coronary artery calcification (CAC) was assessed using the CT images. The impact of CKD on arterial inflammation and CAC was then assessed.
Results:
Arterial inflammation was higher in patients with CKD than in matched controls (standardized uptake value, SUV: 2.41 ± 0.49 vs. 2.16 ± 0.43; p = 0.002). Arterial SUV correlated inversely with eGFR (r = -0.299, p = 0.001). Venous SUV was also significantly elevated in patients with CKD, while subcutaneous fat and muscle tissue SUVs did not differ between groups. Moreover, arterial SUV remained significantly elevated in patients with CKD compared to controls after correcting for muscle and fat background, and also remained significant after adjusting for clinical risk factors. Further, CKD was associated with arterial inflammation (SUV) independent of the presence of subclinical atherosclerosis (CAC).
Conclusion:
Moderate CKD is associated with increased arterial inflammation beyond that of controls. Further, the increased arterial inflammation is independent of presence of subclinical atherosclerosis. Current risk stratification tools may underestimate the presence of atherosclerosis in patients with CKD and thereby the risk of cardiovascular events.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology

